Clinical Trials
26 trialsDetermine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
M.D. Anderson Cancer Center
Positron Emission Mammography and Liquid Biopsy in Women With High-risk Breast Screenings
University Health Network, Toronto
Biomarkers to Detect Endocrine Therapy Resistance
University of Wisconsin, Madison
Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab
CHA University
Role of ctDNA in Genetic Profiling & Outcomes for Advanced BTC
CHA University
ctDNA in Genetic Profiling and Clinical Outcomes of Advanced Biliary Tract Cancer
CHA University
GALIA
Institute of Oncology Ljubljana
Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
The Institute of Molecular and Translational Medicine, Czech Republic
Liquid Biopsy-Based Pre-Screening to Streamline LDCT Lung Cancer Screening in High-Risk Individuals
National University Hospital, Singapore
NF1-TED
Boston Children's Hospital
TRICIA
Jewish General Hospital
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
City of Hope Medical Center
COPE
Institut Bergonié
SMART
Erasmus Medical Center
HOPE-PROSTATE
SOLTI Breast Cancer Research Group
LILIPSY
University Hospital, Montpellier
French Assessment of MRD by Liquid Biopsies in PDAC Patients (FRENCH.MRD.PDAC)
University Hospital, Montpellier
PRISM-POrTAL
Gustave Roussy, Cancer Campus, Grand Paris
HOPE-Focus
SOLTI Breast Cancer Research Group
CoLiQ
Helse Nord-Trøndelag HF
PeRFormanCe
University Hospital, Ghent
NevustoMel
Fundacion Clinic per a la Recerca Biomédica
Precis-mel 2
Fundacion Clinic per a la Recerca Biomédica
ZERO2
Australian & New Zealand Children's Haematology/Oncology Group
Liquid Biopsy in Mature B-cell Tumors
Oncology Institute of Southern Switzerland
Prediction of Postoperative Treatment Efficacy and Recurrence Risk of High-risk GIST Based on Liquid Biopsy MRD
Peking University People's Hospital